Viewing Study NCT01158261


Ignite Creation Date: 2025-12-24 @ 11:45 AM
Ignite Modification Date: 2025-12-29 @ 11:10 AM
Study NCT ID: NCT01158261
Status: COMPLETED
Last Update Posted: 2015-08-19
First Post: 2010-07-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Evicel Post-Authorization Surveillance Study
Sponsor: Ethicon, Inc.
Organization:

Study Overview

Official Title: A Prospective, Single-Arm, Observational, Non-interventional Study for EVICEL ™ Fibrin Sealant (Human) When Used as an Adjunct to Haemostasis in Vascular Surgery
Status: COMPLETED
Status Verified Date: 2015-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this non-interventional Post Authorisation Safety Surveillance (PASS) study is to observe the clinical safety performance of EVICEL when used as suture support for haemostasis in vascular surgery.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: